[HTML][HTML] Treatments for COVID-19: Lessons from 2020 and new therapeutic options

F Salasc, T Lahlali, E Laurent, M Rosa-Calatrava… - Current Opinion in …, 2022 - Elsevier
To face the COVID-19 pandemic, prophylactic vaccines have been developed in record
time, but vaccine coverage is still limited, accessibility is not equitable worldwide, and the …

[HTML][HTML] Update on antiviral strategies against COVID-19: unmet needs and prospects

CH Liu, CH Lu, SH Wong, LT Lin - Frontiers in Immunology, 2021 - frontiersin.org
By December 2020, the COVID-19 pandemic had caused more than 74 million confirmed
cases and 1.6 million related deaths around the world. However, only a few drugs have …

[HTML][HTML] Repurposing drugs, ongoing vaccine, and new therapeutic development initiatives against COVID-19

RP Saha, AR Sharma, MK Singh, S Samanta… - Frontiers in …, 2020 - frontiersin.org
As the COVID-19 is still growing throughout the globe, a thorough investigation into the
specific immunopathology of SARS-CoV-2, its interaction with the host immune system and …

A comprehensive review on potential therapeutics interventions for COVID-19

H Chugh, A Awasthi, Y Agarwal, RK Gaur… - European Journal of …, 2021 - Elsevier
COVID-19 is an infectious respiratory disease caused by SARS-CoV-2, a new beta
coronavirus that emerged in Wuhan, China. Being primarily a respiratory disease, it is highly …

[PDF][PDF] COVID-19 Treatment: The Race Against Time. Electron J Gen Med. 2020; 17 (6): em227

M Aljofan, A Gaipov - 2020, 2020 - ejgm.co.uk
The new outbreak of the novel coronavirus infection emerged in Wuhan-China in late 2019,
by the end of Mar 2020, it has spread in more than 178 countries and territories. There is no …

[HTML][HTML] Overview of antiviral drug therapy for COVID-19: where do we stand?

R Esposito, D Mirra, L Sportiello, G Spaziano… - Biomedicines, 2022 - mdpi.com
The vaccine weapon has resulted in being essential in fighting the COVID-19 outbreak, but it
is not fully preventing infection due to an alarming spreading of several identified variants of …

COVID-19 therapeutics: Challenges and directions for the future

PC Robinson, DFL Liew, HL Tanner… - Proceedings of the …, 2022 - National Acad Sciences
The emergence of SARS-CoV-2 triggering the COVID-19 pandemic ranks as arguably the
greatest medical emergency of the last century. COVID-19 has highlighted health disparities …

[HTML][HTML] Drugs for COVID-19: An update

J Ceramella, D Iacopetta, MS Sinicropi, I Andreu… - Molecules, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …

Different drug approaches to COVID-19 treatment worldwide: an update of new drugs and drugs repositioning to fight against the novel coronavirus

JC Oliver, EN Silva, LM Soares… - … in Vaccines and …, 2022 - journals.sagepub.com
According to the World Health Organization (WHO), in the second half of 2022, there are
about 606 million confirmed cases of COVID-19 and almost 6,500,000 deaths around the …

COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials

R Chakraborty, S Parvez - Biochemical pharmacology, 2020 - Elsevier
COVID-19, the greatest public health emergency of the 21st century, has affected 215
countries and territories around the world resulting in 15,151,738 confirmed cases and …